Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Scott Foley keeps his personal life private but doesn’t hesitate to talk about how much he loves his family, including his ...

Background: Variable rates of HER2 protein ... HER2-positive (fluorescence in situ hybridization [FISH] positive) ovarian cancer progressing under taxane/carboplatin chemotherapy or in early ...

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Staff at the Penn Vet Working Dog Center (PVWDC) agree, which is why Ken, a member of Canada Task Force 2, has recently ...

With this acquisition, LipoVation becomes a wholly owned subsidiary of Revium Rx, aligning with the company’s renewed commitment to drug delivery innovation. Revium Rx is developing a portfolio of ...

Research suggests that dogs have an extraordinary ability to detect illness, including cancer, through their sense of smell. The idea first emerged in 1989 when a woman noticed her dog persistently ...

PRINCETON - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company specializing in immunotherapy treatments with a current market capitalization of $4.69 million, ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.